Why More Foreigners Are Seeking Health Care in China?

It’s 7 a.m. in Ho Chi Minh City. Minh is scrolling through yet another insurance rejection for his mother’s PET-CT scan, while in Singapore, Priya stares at a S$8,000 bill for an executive health screening she was told would take three weeks to schedule. Both are asking the same question: is there a faster, more affordable way without compromising quality? For a growing number of patients across Southeast Asia, the answer is China — not as a workaround, but as a genuine alternative built on the same equipment, comparable clinical standards, and a fraction of the cost.

Key Facts

• A comprehensive executive health screening in Singapore costs S$3,000–S$10,000; an equivalent package in China costs US$800–US$2,500 — 40–60% less, usually completed within a single 1–2 day visit.
• As of July 2026, China has nine NMPA-approved CAR-T products, including the world’s first approved CAR-T for a solid tumour. Official list prices run roughly US$125,000–US$215,000, versus US$400,000–US$500,000 for equivalent approved products in the US.
• Commercial CAR-T — not a clinical trial — is the realistic, predictable pathway for most international patients; China Care’s preliminary screening will tell you honestly which applies to your case.
• Flight times from Southeast Asia to major Chinese medical hubs are short: Ho Chi Minh City to Guangzhou is approximately 3 hours; Singapore to Shanghai is approximately 5 hours.
• China has more active CAR-T clinical trials than any other country, but enrollment for first-time overseas patients is selective, not guaranteed.

Why More Foreigners Are Seeking Health Care in China? The Trend That’s Reshaping China Medical Tourism

The Pain Point in Singapore and Vietnam

In Singapore, a comprehensive executive health screening at a private hospital can cost S$3,000 to S$10,000 — and scheduling often means a two-to-three week wait. In Vietnam, many advanced diagnostics (PET-CT, high-resolution MRI) require travel to Hanoi or Ho Chi Minh City and still face equipment queues. For cancer patients specifically, the gap is starker: an approved CAR-T product in the US or a comparable Western market commonly runs US$400,000–US$500,000 for the drug alone, before hospitalisation.

What China Offers

China’s Grade-3A university hospitals and international hospitals now operate PET-MRI, AI-assisted imaging, robotic surgery systems, and advanced radiation therapy — equipment matching or exceeding Western standards. The structural advantage is throughput: high patient volumes mean same-day or next-day imaging slots are the norm, not the exception. On the treatment side, China’s National Medical Products Administration (NMPA) has approved nine CAR-T products by mid-2026, giving international patients a commercial — not experimental — pathway to a therapy still priced out of reach for most patients in Southeast Asia and beyond.

The Reality for Singaporean and Vietnamese Patients

A comprehensive screening package in China — including advanced imaging, endoscopy, blood panels, and specialist review — typically costs US$800 to US$2,500. That is 40–60% less than comparable private packages in Singapore. China’s screening centres and Grade-3A hospitals operate under national accreditation standards, and several partner centres carry international quality certifications specific to their facility.

Full Body Check-Ups in China: Not Just a Routine Screen — a Deep Diagnostic Experience

A full body checkup in China at a top-tier screening centre goes well beyond a standard annual physical. Packages at partner centres include full-body MRI, low-dose CT for lung cancer screening, tumour marker blood panels, cardiac stress testing and echocardiogram, abdominal and thyroid ultrasound, DEXA bone density scanning, and a specialist review consultation — typically delivered within one to two days, with digital results issued in 3–7 working days.

The “1+X” Model: A Baseline Package, Tailored to You

Most Chinese screening centres structure their programmes around a “1+X” model: a comprehensive baseline package (the “1”) covering core imaging, blood work, and cardiac and cancer screening, with individually selected add-ons (the “X”) layered on top based on age, family history, and personal risk factors. A patient with a family history of colorectal cancer might add a sedated colonoscopy; someone with cardiovascular risk factors might add coronary calcium scoring or advanced cardiac MRI. This risk-stratified approach means you are not paying for tests you do not need, and not missing the ones that matter for your specific profile.

Where International Patients Actually Go

China Care coordinates screening bookings with three leading dedicated health screening chains, each operating purpose-built screening facilities rather than general hospital wards:

• JD Health Screening Centres — part of JD Health (HKEX: 6618), with fully digital booking and paperless intake across Beijing and Shenzhen.
• Meinian Onehealth Screening Centres — China’s largest private health screening network, covering 200+ cities, useful for patients visiting secondary cities beyond the major hubs.
• Ruici Health Screening Centres — a premium-positioned chain concentrated in Shanghai, Jiangsu, and Zhejiang, known for tiered VIP programmes.

For patients who need same-visit specialist follow-up on a screening finding, China Care also coordinates with public tertiary hospitals such as Peking Union Medical College Hospital in Beijing and Shanghai Jiahui International Hospital, a private international facility whose facility standards are aligned with JCI benchmarks. Reports from all Chinese screening centres are issued in Chinese as standard; professional human translation for your GP or insurer at home can be arranged separately on request.

What Happens If Something Is Found

The main anxiety around any health screening is what happens if a finding needs follow-up. At China’s leading screening centres, an abnormal result triggers an immediate same-day or next-day physician consultation, not a multi-week referral queue. If the finding warrants specialist oncology or cardiology review, China Care coordinates a direct handoff to a partner hospital’s relevant department, carrying your imaging and blood work forward so nothing is repeated unnecessarily.

Preparing for Your Screening Day

Most comprehensive packages require fasting from midnight the night before, since blood panels and abdominal ultrasound both need an empty stomach for accurate results. If your package includes a sedated colonoscopy or gastroscopy, bowel preparation typically starts the evening before as well — your coordinator sends a preparation guide once your appointment is confirmed, so there are no surprises on the day. Bring any recent prior scans, blood test results, or specialist letters from home; Chinese physicians use these to compare changes over time and to personalise which parts of your “X” add-ons are worth prioritising. Most screening visits run from early morning to early afternoon, leaving the rest of the day free — a meaningful difference from the multi-day process common at busy Western private hospitals.

Cancer Treatment in China: NMPA-Approved CAR-T, Not Just Clinical Trials

China’s Oncology Advantage

Cancer immunotherapy in Western markets can exceed US$100,000 annually, a burden documented in NCI cancer statistics. For CAR-T cell therapy specifically, the more meaningful comparison for most patients is not a clinical trial price — it is the cost of an NMPA-approved commercial product, which is the realistic pathway for the large majority of international patients.

As of July 2026, China’s oncology infrastructure includes:

• Nine NMPA-approved CAR-T products, spanning CD19, BCMA, and — as of June 2026 — CLDN18.2 targets. This includes satricabtagene autoleucel (satri-cel), the world’s first commercially approved CAR-T product for a solid tumour (CLDN18.2-positive gastric and gastroesophageal junction adenocarcinoma). Official manufacturer list prices run roughly US$125,000–US$215,000 depending on the product and current exchange rate, versus US$400,000–US$500,000 for equivalent approved products in the US. See our full CAR-T cost comparison guide for a product-by-product breakdown.
• Proton therapy at the Shanghai Proton and Heavy Ion Center and other facilities.
• 200+ active CAR-T clinical trials — more than any other country, as indexed on ClinicalTrials.gov — genuinely valuable for patients whose diagnosis does not fit an approved product, but access for first-time overseas patients is selective. Recruitment is managed by the research team, and places are typically offered first to patients already established within that hospital’s domestic referral network. Treat trial access as a possibility worth exploring, not a plan to rely on.
• Integrative oncology (Traditional Chinese Medicine as supportive care) offered alongside standard Cancer Treatment protocols.

India and Thailand have no NMPA- or locally approved CAR-T products; patients in those markets cannot access this treatment category as a commercial option at all.

Setting the Right Expectations Before You Travel

The single most useful thing China Care does for a new cancer patient is tell them, honestly and before they book any travel, whether their diagnosis matches an approved commercial product or whether they are genuinely a candidate for a clinical trial. Confusing the two leads to disappointment. A commercial CAR-T pathway has a predictable timeline once a specialist confirms eligibility; a trial pathway does not, and first-time overseas enrollment should never be assumed.

From Ho Chi Minh to Guangzhou, Singapore to Shanghai: Travel, Language, and Peace of Mind

Flight times from regional hubs make China a practical choice:

• Ho Chi Minh City to Guangzhou: approximately 3 hours
• Hanoi to Shanghai: approximately 3.5 hours
• Singapore to Guangzhou: approximately 4 hours
• Singapore to Shanghai: approximately 5 hours

These times are comparable to — or shorter than — travelling to other medical tourism destinations. For guidance on documentation, see the Medical Visa Guide; most screening and treatment visits under 180 days use an S2 medical visa, supported by an official hospital invitation letter.

What the Visa Process Actually Looks Like

The S2 medical visa is not something you can apply for on your own without the hospital’s involvement first. The sequence runs: your case is reviewed and an appointment confirmed, the licensed Chinese hospital itself issues the official invitation letter — on hospital letterhead with an official stamp, naming your treating department and estimated stay — and you take that letter, along with your own supporting documents (passport, medical records, application form), to your nearest Chinese Visa Application Service Centre.

China Care coordinates this process and guides you through what to prepare, but the invitation letter itself can only come from the treating hospital, not from a facilitator. Processing at the Visa Application Service Centre after a complete application is submitted typically takes around 4 business days, though this varies by embassy and season. Nationals of some Southeast Asian countries also have visa-free transit options for short diagnostic visits, but any stay involving hospital admission or a multi-day treatment course should be documented properly with an S2 visa — travelling on a tourist visa for treatment purposes can create complications at immigration on both entry and exit.

Where You Stay, and Who Is With You

Most partner hospitals and screening centres are within walking distance, or a short taxi ride, of recommended international-standard hotels, and China Care can advise on accommodation options based on your budget and how long you expect to stay. For patients undergoing multi-week treatment such as CAR-T therapy, hospital-adjacent accommodation for a caregiver or family member is coordinated separately from the hospital admission itself, since most Chinese hospitals house the patient in a single-occupancy or shared ward rather than a hotel-style suite.

Wuhan Tongji Hospital and other partner institutions operate dedicated international departments with English-language coordinators and interpretation services throughout the consultation and treatment process.

How China Care Health Tours Simplifies Your Journey

China Care is a navigation and coordination service, not a hospital or treatment provider. We handle S2 medical visa documentation, medical interpretation, accommodation logistics, and on-ground advocacy throughout your visit, and we work with a vetted network of screening centres and Grade-3A hospitals evaluated by our own team. For an overview of the best countries for medical tourism in 2026, see our global comparison guide.

Start your free preliminary screening for cancer treatment enquiries, or ask us which screening centre suits your itinerary — response within 24 hours, no obligation. For a deeper look at health screening options, see our full guide to health screening in China for foreigners.

Frequently Asked Questions

References

1. China Care Health Tours — Guide to Medical Treatment in China for Foreigners: https://chinacarehealthtours.com/a-guide-to-medical-treatment-in-china-for-foreigners/
2. China Care Health Tours — Health Screening in China for Foreigners: https://chinacarehealthtours.com/health-screening-in-china-for-foreigners/
3. China Care Health Tours — CAR-T Cell Therapy Cost: China vs USA 2026: https://chinacarehealthtours.com/car-t-cell-therapy-cost-in-china-vs-usa-2026-comparison-guide/
4. China Care Health Tours — CAR-T Cell Therapy in China: https://chinacarehealthtours.com/car-t-cell-therapy-in-china/
5. China Care Health Tours — Shanghai Proton and Heavy Ion Center: https://chinacarehealthtours.com/sphic/
6. China Care Health Tours — Wuhan Tongji Hospital: https://chinacarehealthtours.com/hospitals/wuhan/wuhan-tongji-hospital/
7. China Care Health Tours — Medical Visa Guide 2026: https://chinacarehealthtours.com/how-to-get-a-medical-visa-for-china-a-complete-2026-guide/
8. China Care Health Tours — China vs Singapore for Medical Tourism: https://chinacarehealthtours.com/china-vs-singapore-medical-tourism-2026/
9. National Cancer Institute — Cancer statistics: https://www.cancer.gov/about-cancer/understanding/statistics
10. National Comprehensive Cancer Network — Clinical Practice Guidelines: https://www.nccn.org/guidelines/category_1
11. ClinicalTrials.gov — CAR-T trials registered in China: https://clinicaltrials.gov/search?cond=CAR-T&locn=China